Shares of Medicure Inc. (CVE:MPH – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 1000 shares traded. The stock had previously closed at C$0.87.
Medicure Stock Down 5.7 %
The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.29 and a current ratio of 1.87. The firm has a market capitalization of C$8.56 million, a price-to-earnings ratio of -3.28 and a beta of 0.90. The firm has a fifty day moving average price of C$0.92 and a 200 day moving average price of C$0.99.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- How to Invest in Blue Chip Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What to Know About Investing in Penny Stocks
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Overbought Stocks Explained: Should You Trade Them?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
